Ebos revises share trading policy after director transgression
New rules tighten policy on using margin loans.
Wed, 04 May 2022
Medical products distributor and petfood group Ebos has revised its securities trading policy, three months after the Financial Markets Authority said it was looking into trading by former director Nick Dowling.
Ebos has consistently declined to comment on unauthorised share trading by Dowling,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
